DNA Chip Research Inc. (TYO:2397)
Japan
· Delayed Price · Currency is JPY 1,090.00
-1.00 (-0.09%)
Jun 6, 2025, 2:36 PM JST
DNA Chip Research Revenue
In the fiscal year ending March 31, 2025, DNA Chip Research had annual revenue of 1.09B JPY with 122.65% growth. DNA Chip Research had revenue of 348.00M in the quarter ending March 31, 2025, with 58.90% growth.
Revenue
1.09B
Revenue Growth
+122.65%
P/S Ratio
6.76
Revenue / Employee
29.49M
Employees
37
Market Cap
7.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.09B | 601.00M | 122.65% |
| Mar 31, 2024 | 490.00M | 163.00M | 49.85% |
| Mar 31, 2023 | 327.00M | -100.00M | -23.42% |
| Mar 31, 2022 | 427.00M | 103.00M | 31.79% |
| Mar 31, 2021 | 324.00M | -37.00M | -10.25% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |